Dr. Dobri Kiprov speaks about Therapeutic Plasma Exchange at Rejuvenation Startup Summit 2022

We are happy to announce Dr. Dobri Kiprov, M.D., H.P. (ASCP), Co-founder and CSO of Lyfspn, as a speaker for the Rejuvenation Startup Summit 2022. 

Dobri will talk about Therapeutic Plasma Exchange and Lyfspn, Inc. – carrying out a pilot study on their lead longevity promoting therapy candidate, a novel apheresis-based treatment. 

Dobri Kiprov, M.D., H.P. (ASCP) is an internationally renowned pioneer and expert in Therapeutic Apheresis, Immunotherapy, Long Covid and Age Related Disorders. 

Dr. Kiprov has worked in the field of Therapeutic Apheresis for more than 30 years and has published extensively on this subject. Dr. Kiprov served two terms on the American Society for Apheresis (ASFA) Board of Directors and created the first ASFA educational video program. He is also the first physician to take and pass the Hemapheresis Practitioner Exam (ASCP). Dr. Kiprov is the recipient of the ASFA Presidential Award for his pioneering work and numerous contributions to the field of apheresis and the Society. He is also the recipient of the ASFA Lecturers Award and the Francis Morrison Memorial Award.

Dr. Kiprov is one of the first physicians in the United States to complete a formal fellowship program in Clinical Immunology and Immunopathology (Massachusettes General Hospital and Harvard Medical School, sponsored by the NIH). Dr. Kiprov’s accomplishments in the field of Immunology are reflected in his numerous publications including the first description of new Immunologically Related Syndromes. With his immunology and apheresis background, Dr. Kiprov has been a part of the first trials of immunotherapy (cell therapies) and is currently involved in several projects involving Cell vaccines and CAR-T cell therapies.

Dr. Kiprov was the first to publish on the effect of Therapeutic Plasma Exchange (TPE) on aging. He is Co-founder and CSO of Lyfspn, Inc.

About the Rejuvenation Startup Summit 2022

The Rejuvenation Startup Summit (Berlin, Oct. 14-15, 2022) hosted by the Forever Healthy Foundation, is a vibrant networking event that aims to accelerate the development of the rejuvenation biotech industry.

Rejuvenation/Longevity biotech is a new, emerging field of medicine. It aims to prevent and reverse diseases of aging by addressing their common root cause, the aging process itself. Rejuvenation therapies aim to reverse or repair age-related cellular changes such as molecular waste, calcification, tissue stiffening, loss of stem cell function, genetic alterations, and impaired energy production.

The Rejuvenation Summit brings together startups, members of the longevity venture capital / investor ecosystem, and researchers interested in founding or joining a startup – all aiming to create therapies to vastly extend the healthy human lifespan.

Further information can be found at

About Lyfspn, Inc.

Lyfspn, a company backed by Khosla Ventures, is a physician-led startup company working to invent novel therapies that will allow us to live longer, healthier lives. The Lyfspn team is passionate about bringing therapies to the world that find their basis in basic science research. Lyfspn is currently planning to carry out a pilot study on our lead longevity promoting therapy candidate, a novel apheresis based treatment. 

Further information can be found at